These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 8942890

  • 21. A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data.
    Nordmann JP, Mertz B, Yannoulis NC, Schwenninger C, Kapik B, Shams N, Unoprostone Monotherapy Study Group-EU.
    Am J Ophthalmol; 2002 Jan; 133(1):1-10. PubMed ID: 11755834
    [Abstract] [Full Text] [Related]

  • 22. Around-the-clock intraocular pressure reduction with once-daily application of latanoprost by itself or in combination with timolol.
    Rácz P, Ruzsonyi MR, Nagy ZT, Gaygi Z, Bito LZ.
    Arch Ophthalmol; 1996 Mar; 114(3):268-73. PubMed ID: 8600885
    [Abstract] [Full Text] [Related]

  • 23. A 12-week, randomized, double-masked, multicenter study of the fixed combination of latanoprost and timolol in the evening versus the individual components.
    Diestelhorst M, Larsson LI, European-Canadian Latanoprost Fixed Combination Study Group.
    Ophthalmology; 2006 Jan; 113(1):70-6. PubMed ID: 16263174
    [Abstract] [Full Text] [Related]

  • 24. Comparison between latanoprost and brimonidine efficacy and safety in Indian eyes.
    Thomas R, Parikh R, Muliyil J, George R, Paul P, Abraham LM.
    Indian J Ophthalmol; 2003 Jun; 51(2):123-8. PubMed ID: 12831141
    [Abstract] [Full Text] [Related]

  • 25. A comparison of travoprost, latanoprost, and the fixed combination of dorzolamide and timolol in patients with pseudoexfoliation glaucoma.
    Parmaksiz S, Yüksel N, Karabas VL, Ozkan B, Demirci G, Caglar Y.
    Eur J Ophthalmol; 2006 Jun; 16(1):73-80. PubMed ID: 16496249
    [Abstract] [Full Text] [Related]

  • 26. Comparative analysis of the efficacy and safety of latanoprost, travoprost and the fixed combination timolol-dorzolamide; a prospective, randomized, masked, cross-over design study.
    Chiseliţă D, Antohi I, Medvichi R, Danielescu C.
    Oftalmologia; 2005 Jun; 49(3):39-45. PubMed ID: 16408674
    [Abstract] [Full Text] [Related]

  • 27. Efficacy and safety of latanoprost eye drops for glaucoma treatment: a 1-year study in Japan.
    Suzuki M, Mishima HK, Masuda K, Araie M, Kitazawa Y, Azuma I.
    Jpn J Ophthalmol; 2000 Jun; 44(1):33-8. PubMed ID: 10698023
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Randomized parallel group study of 0.0015% tafluprost ophthalmic solution in patients with primary open-angle glaucoma or ocular hypertension (comparison with 0.005% latanoprost ophthalmic solution)].
    Ge J, Li X, Sun X, He X, Zhang H.
    Zhonghua Yan Ke Za Zhi; 2015 Feb; 51(2):95-102. PubMed ID: 25907999
    [Abstract] [Full Text] [Related]

  • 30. Fixed combination of latanoprost and timolol vs individual components for primary open-angle glaucoma or ocular hypertension: a randomized, double-masked study.
    Higginbotham EJ, Olander KW, Kim EE, Grunden JW, Kwok KK, Tressler CS, United States Fixed-Combination Study Group.
    Arch Ophthalmol; 2010 Feb; 128(2):165-72. PubMed ID: 20142538
    [Abstract] [Full Text] [Related]

  • 31. Pneumatic trabeculoplasty vs latanoprost as adjunctive therapy to timolol in primary open-angle glaucoma or ocular hypertension.
    Uva MG, Longo A, Reibaldi M.
    Graefes Arch Clin Exp Ophthalmol; 2009 Aug; 247(8):1103-9. PubMed ID: 19247684
    [Abstract] [Full Text] [Related]

  • 32. Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group.
    Bucci MG.
    J Glaucoma; 1999 Feb; 8(1):24-30. PubMed ID: 10084271
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Topical bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension.
    Easthope SE, Perry CM.
    Drugs Aging; 2002 Feb; 19(3):231-48. PubMed ID: 12027782
    [Abstract] [Full Text] [Related]

  • 38. The efficacy and safety of the timolol/dorzolamide fixed combination vs latanoprost in exfoliation glaucoma.
    Konstas AG, Kozobolis VP, Tersis I, Leech J, Stewart WC.
    Eye (Lond); 2003 Jan; 17(1):41-6. PubMed ID: 12579169
    [Abstract] [Full Text] [Related]

  • 39. Three-month comparison of brimonidine and latanoprost as adjunctive therapy in glaucoma and ocular hypertension patients uncontrolled on beta-blockers: tolerance and peak intraocular pressure lowering.
    Simmons ST, Earl ML, Alphagan/Xalatan Study Group.
    Ophthalmology; 2002 Feb; 109(2):307-14; discussion 314-5. PubMed ID: 11825814
    [Abstract] [Full Text] [Related]

  • 40. Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension.
    Lesk MR, Koulis T, Sampalis F, Sampalis JS, Bastien NR.
    Ann Pharmacother; 2008 Apr; 42(4):498-504. PubMed ID: 18364402
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.